UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035466
Receipt number R000040404
Scientific Title Evaluation of endocrine disorders in IgG4 related disease: prospective cohort study.
Date of disclosure of the study information 2023/03/31
Last modified on 2019/01/06 23:04:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of endocrine disorders in IgG4 related disease: prospective cohort study.

Acronym

Evaluation of endocrine disorders in IgG4 related disease

Scientific Title

Evaluation of endocrine disorders in IgG4 related disease: prospective cohort study.

Scientific Title:Acronym

Evaluation of endocrine disorders in IgG4 related disease

Region

Japan


Condition

Condition

IgG4 related disease

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the association between biological parameters and endocrine disorders before and after steroid therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Parameters associated with endocrine function

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with IgG4 related disease

Key exclusion criteria

Patients with allergic disease, collagen disease, hepatitis and Nephritis

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ken Takeshima

Organization

Wakayama Medical University

Division name

First department of medicine

Zip code


Address

811-1 Kimi-idera, Wakayama-City, Wakayama

TEL

073-441-0625

Email

kt10948@wakayama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ken Takeshima

Organization

Wakayama Medical University

Division name

First department of medicine

Zip code


Address

811-1 Kimi-idera, Wakayama-City, Wakayama

TEL

073-441-0625

Homepage URL


Email

kt10948@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

2115

Org. issuing International ID_1

Wakayama Medical University Hospital Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2018 Year 08 Month 31 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2019 Year 01 Month 06 Day

Last modified on

2019 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040404